| __timestamp | Catalyst Pharmaceuticals, Inc. | Iovance Biotherapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4473654 | 9335772 |
| Thursday, January 1, 2015 | 8597010 | 12390000 |
| Friday, January 1, 2016 | 7910260 | 25602000 |
| Sunday, January 1, 2017 | 7304399 | 21262000 |
| Monday, January 1, 2018 | 15875961 | 28430000 |
| Tuesday, January 1, 2019 | 36881187 | 40849000 |
| Wednesday, January 1, 2020 | 44233754 | 60210000 |
| Friday, January 1, 2021 | 49628000 | 83664000 |
| Saturday, January 1, 2022 | 58183000 | 104097000 |
| Sunday, January 1, 2023 | 133710000 | 106916000 |
Data in motion
In the dynamic world of biotechnology, understanding financial trends is crucial for investors and stakeholders. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of two prominent biotech firms: Catalyst Pharmaceuticals, Inc. and Iovance Biotherapeutics, Inc., from 2014 to 2023.
Catalyst Pharmaceuticals has shown a remarkable increase in SG&A expenses, growing nearly 30 times from 2014 to 2023. This surge reflects their aggressive expansion and investment in administrative capabilities. In contrast, Iovance Biotherapeutics, while also experiencing growth, has seen a more moderate increase, with expenses rising by approximately 11 times over the same period.
The year 2023 marks a significant point where Catalyst's expenses surpassed Iovance's, indicating a strategic shift or increased operational costs. These trends offer a window into each company's strategic priorities and market positioning, providing valuable insights for potential investors.
Operational Costs Compared: SG&A Analysis of AbbVie Inc. and Catalyst Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: AstraZeneca PLC vs Iovance Biotherapeutics, Inc.
SG&A Efficiency Analysis: Comparing United Therapeutics Corporation and Catalyst Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Summit Therapeutics Inc. or Catalyst Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Insmed Incorporated and Iovance Biotherapeutics, Inc.
SG&A Efficiency Analysis: Comparing Dr. Reddy's Laboratories Limited and Iovance Biotherapeutics, Inc.
Walgreens Boots Alliance, Inc. and Catalyst Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Exelixis, Inc. or Iovance Biotherapeutics, Inc.
Who Optimizes SG&A Costs Better? Amneal Pharmaceuticals, Inc. or Iovance Biotherapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Catalyst Pharmaceuticals, Inc. and HUTCHMED (China) Limited
Who Optimizes SG&A Costs Better? Catalyst Pharmaceuticals, Inc. or Wave Life Sciences Ltd.
Iovance Biotherapeutics, Inc. or Travere Therapeutics, Inc.: Who Manages SG&A Costs Better?